About US
Contact us
-
WuXi's STA to build massive manufacturing facility in Delaware, adding 500 jobs“Project Dragonfly,” STA Pharmaceutical’s codenamed plan to build a massive manufacturing facility, has emerged from the cover of darkness, brought into the light by a $19 million grant from the stat2021/6/30
-
Amgen pumps $365M into new Ohio 'smart facility,' where 400 staffers will be aided by robots, AI and moreOhio hasrecently proved an alluring target for biopharmas of all sizes, from gene therapy player Sarepta Therapeutics tobiotech-CDMO hybrid Forge Biologics. Now, Big Pharma Amgen is getting in on the2021/6/30
-
In collab with Novo Nordisk, Walmart says it will 'revolutionize' insulin access with deep discountsInsulin costs have been a controversial topic in pharmafor years, with the leading manufacturers facing routine scrutiny for their pricing strategies. In a move poised to shake up themarket, Walmart2021/6/28
-
Novartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: surveyNovartis’ Adakveo and Global Blood Therapeutics’ Oxbryta started their commercial life in 2019 as novel drugs for sickle cell disease. While physicians like their efficacy and safety profiles, formul2021/6/28
-
Jury awards former AstraZeneca sales manager $2.4M in whistleblower retaliation caseAstraZeneca and a former sales manager have each scored partial wins in the case of Suzanne Ivie, who alleged the company fired her after she raised concerns of off-label marketing. While a federal j2021/6/24
-
Horizon lays out $65M for in-house manufacturing plant as eye med Tepezza resets course to blockbusterlandAs Horizon Therapeutics' one-and-a-half-year-old thyroid eye disease med Tepezza starts to spread its wings, the drugmaker is standing up in-house manufacturing to help bluntany further supply disrup2021/6/24
-
With a Delaware site codenamed 'Project Dragonfly,' WuXi's STA plans to add 1,200 jobs in US expansion: reportsIt might sound like a codename in a spy movie spoof, but “Project Dragonfly” is in fact what STA Pharmaceutical has been calling its plan to build a massive manufacturing site in Delaware, according2021/6/23
-
Bristol Myers inks another Revlimid patent settlement—this time with Sun Pharma—as copycats nearAs Bristol Myers Squibb looks to guard Celgene’s top-selling cancer drug Revlimid from copycat competition, the company has inked a series of deals to welcome generic challengers in waves. India’s Su2021/6/23
-
Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, RegeneronAmgen’s high-profile PCSK9 patent fight with Sanofiand Regeneronhas attracted a who’s who of biopharma observers over the years,with many top companiesvoicingsupport foreach side. Now, Amgen has suff2021/6/21
-
Novavax's COVID-19 shot won't see much U.S. use, but a big global market awaits: analystIn rapidly developing a COVID-19 vaccine—and a highly effective one at that—Novavax got the hard part right. But the logistics of manufacturingthe vaccine has proven to be a more daunting task for th2021/6/21